Eukarÿs is proud to announce that it has won the prestigious US Prix Galien MedStartUp 2019 for ‘Best collaboration with the pharmaceutical or biotechnology industry’. The award was presented on October 24 at the Alexandria Life Sciences Center in New York.
The award recognizes Eukarÿs’ partnership with Dr. Maya Shmulevitz’s Molecular Virology and Oncology Laboratory at the University of Alberta. Together they developed the C3P3 system for viral bioproduction, focusing on oncolytic reoviruses for cancer therapy. The prize jury, chaired by Bernard Poussot (Chairman of Roche Holding), included senior executives from Sanofi, GSK, Pfizer, Johnson & Johnson, UCB and Evercore Partners.
This achievement underscores Eukarÿs’ commitment to advancing human health through innovation.

24 octobre 2019
Eukarÿs wins the 2019 US Prix Galien MedStartUp award
You may also be interested in these articles